uBiome Awards Groundbreaking Grant to University of Denver to Study the Role...
The leader in microbial genomics awards grant to University of Denver researchers to analyze association between microbiome composition maternal mood and infant behavior.SAN FRANCISCO PRWEB November 16...
View ArticleDigital Landscape Inflammatory Bowel Disease Report Updated 06092018 Prices...
Digital Landscape Inflammatory Bowel DiseaseSummaryThe Digital Landscape Inflammatory Bowel Disease report analyzes digital activities undertaken by pharma in support of diseasemodifying therapies for...
View ArticleUCB SA UCB Medical Equipment Deals and Alliances Profile Report Updated...
SummaryUCB SA UCB is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the...
View ArticleCrohn's Colitis Foundation Inc Pharmaceuticals Healthcare Deals and Alliances...
SummaryCrohn's Colitis Foundation Inc CCF is a nonprofit organization that provides treatments for crohn's disease and ulcerative colitis. The organization funds studies at medical institutions nurture...
View ArticleMorphoSys Announces Its Licensee Janssen Initiated a Phase 2 Study NOVA to...
DGAPNews MorphoSys AG Key words Study19.11.2018 2201 The issuer is solely responsible for the content of this announcement.PlaneggMunich Germany November 19 2018 MorphoSys Announces Its Licensee...
View ArticleMALADIE de CROHN Un nouveau marqueur pour mieux cibler le traitement
La maladie de Crohn MC une maladie inflammatoire chronique du tractus intestinal est en augmentation constante depuis ces 50 dernires annes. Alors que la condition runit selon les experts un ensemble...
View ArticleToll Like Receptor 8 CD288 or TLR8 Pipeline Review H2 2018 Report Updated...
Toll Like Receptor 8 CD288 or TLR8 Pipeline Review H2 2018SummaryToll Like Receptor 8 CD288 or TLR8 Tolllike receptor 8 is a protein encoded by the TLR8 gene. It control host immune response against...
View ArticleRisk Factors for Postoperative Recurrence in Crohn's Disease
This study aimed to identify predictors of postoperative endoscopic recurrence in Crohn's disease patients who have undergone ileocolonic resection. Alimentary Pharmacology & Therapeutics
View ArticleTakeda Receives Clearance from the European Commission for the Proposed...
NOT FOR RELEASE PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION Takeda...
View ArticleTyrosine Protein Kinase JAK1 Janus Kinase 1 or JAK1 or EC 2.7.10.2 Pipeline...
Tyrosine Protein Kinase JAK1 Janus Kinase 1 or JAK1 or EC 2.7.10.2 Pipeline Review H2 2018SummaryAccording to the recently published report 'Tyrosine Protein Kinase JAK1 Pipeline Review H2 2018';...
View ArticleTheravance doses first patient in Phase II trial of Crohns drug
Theravance Biopharma has dosed the first patient in a Phase II clinical trial assessing the efficacy safety and tolerability of...Read More...The post Theravance doses first patient in Phase II trial...
View ArticleUCB SA UCB Pharmaceuticals Healthcare Deals and Alliances Profile Report...
SummaryUCB SA UCB is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the...
View ArticleProtein Phosphatase 2A PP2A or EC 3.1.3.16 Pipeline Review H2 2018 Report...
Protein Phosphatase 2A PP2A or EC 3.1.3.16 Pipeline Review H2 2018SummaryProtein Phosphatase 2A PP2A or EC 3.1.3.16 pipeline Target constitutes close to 8 molecules. Out of which approximately 6...
View ArticleMedical News Today What is the difference between IBS and IBD
Crohn's disease and ulcerative colitis are both types of inflammatory bowel disease IBD. Another condition called irritable bowel syndrome IBS can cause similar symptoms to IBD. However IBD and IBS are...
View ArticleTyrosine Protein Kinase JAK3 Janus Kinase 3 or Leukocyte Janus Kinase or JAK3...
Tyrosine Protein Kinase JAK3 Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2 Pipeline Review H2 2018SummaryTyrosine Protein Kinase JAK3 Janus Kinase 3 or Leukocyte Janus Kinase or JAK3...
View ArticleVIDEO RedHill Unveils Plans For Pivotal Phase III Study For Crohns Therapy
RedHill Biopharmas study results for its novel antibiotic approach to Crohns disease has left the company with some unanswered questions...&160;&160;&160;
View ArticleRedHill Biopharma Ltd RDHL Pharmaceuticals Healthcare Deals and Alliances...
SummaryRedHill Biopharma Ltd RedHill is a biopharmaceutical company that develops and commercializes therapeutics in the areas of gastroenterology GI and cancer. The company's commercial product...
View ArticleDeciphera Pharmaceuticals LLC DCPH Pharmaceuticals Healthcare Deals and...
SummaryDeciphera Pharmaceuticals LLC Deciphera Pharmaceuticals is a research and development company that develops designs and commercializes kinase inhibiting drugs. The company provides clinical...
View ArticleuBiome Appoints Dr. Emeran Mayer MD WorldRenowned Gastroenterologist and...
The leader in microbial genomics appoints functional gastrointestinal disorders expert to its board of medical advisors.SAN FRANCISCO PRWEB November 23 2018 uBiome the leader in microbial genomics...
View ArticleFrost & Sullivan Publishes Q32018 Update Report on RedHill Biopharma Ltd....
Equity Research is published in the framework of the Tel Aviv Stock Exchange TASE Analysis Program TEL AVIV Israel Nov. 23 2018 PRNewswire The TASE analysis project was launched in 2016 ...
View Article